Genomics of Immunotherapy-Associated Hyperprogressors-Letter

Clin Cancer Res. 2017 Oct 15;23(20):6374-6375. doi: 10.1158/1078-0432.CCR-17-1480.

Andrea Forschner¹, Heike Niessner², Yvonne Möller³, Peter Horak⁴, Martina Fröhlich^{5

6}, Gregor Warsow⁷, Albrecht Stenzinger^{8

5}, Stefan Fröhling^{4

5}, Hanno Glimm^{4

5}, Bernhard Klumpp⁹, Claus Garbe², Tobias Sinnberg²

¹ Department of Dermatology, University Hospital, Tuebingen, Germany. andrea.forschner@med.uni-tuebingen.de.
² Department of Dermatology, University Hospital, Tuebingen, Germany.
³ Center for Personalised Medicine, University Hospital, Tuebingen, Germany.
⁴ Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Section for Personalized Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.
⁵ German Cancer Consortium (DKTK), Heidelberg, Germany.
⁶ Division Applied Bioinformatics, DKFZ and NCT, Heidelberg, Germany.
⁷ Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁸ Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
⁹ Department of Radiology, University Hospital, Tuebingen, Germany.

No abstract available

Publication types